Exacerbation risk and characterisation of the UK’s asthma population from infants to old age

BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2018-04, Vol.73 (4), p.313-320
Hauptverfasser: Bloom, Chloe I, Nissen, Francis, Douglas, Ian J, Smeeth, Liam, Cullinan, Paul, Quint, Jennifer K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 320
container_issue 4
container_start_page 313
container_title Thorax
container_volume 73
creator Bloom, Chloe I
Nissen, Francis
Douglas, Ian J
Smeeth, Liam
Cullinan, Paul
Quint, Jennifer K
description BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.
doi_str_mv 10.1136/thoraxjnl-2017-210650
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1957460976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2020443565</sourcerecordid><originalsourceid>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</originalsourceid><addsrcrecordid>eNqNkcFO3DAURa0KVAboJxRZYsMm7bPj2OMlGgFFHakb2GLZjt1kSOLBdiS662_we3xJM8qUBStWT3r33KundxH6SuAbISX_npsQ9fNm6AoKRBSUAK_gE1oQxpdFSSU_QAsABgUvBT9CxyltAGBJiPiMjqgEwZaELdDD1bO2Lhqd2zDg2KZHrIca20ZHbbObFrMSPM6Nw_c_X_--JKxTbnqNt2E7drPuY-hxO3g95IRzwKGrsf7tTtGh111yX_bzBN1fX92tfhTrXze3q8t1YRitcuEZGOuprLn1bik9lEZazrn2kjBdOw5MW25syUnlDKucENSABVEyQqW15Qm6mHO3MTyNLmXVt8m6rtODC2NSRFaCcZCCT-j5O3QTxjhM1ykKFBgrK15NVDVTNoaUovNqG9texz-KgNoVoN4KULsC1FzA5Dvbp4-md_Wb6__HJwBmwPSbD2b-AyTklPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2020443565</pqid></control><display><type>article</type><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</creator><creatorcontrib>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</creatorcontrib><description>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2017-210650</identifier><identifier>PMID: 29074814</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adolescent ; Adult ; Age ; Aged ; Antibiotics ; Asthma ; Asthma - diagnosis ; Asthma - drug therapy ; Asthma - epidemiology ; Asthma - mortality ; Body Mass Index ; Child ; Child, Preschool ; Chronic obstructive pulmonary disease ; Clinical medicine ; Codes ; Cohort Studies ; Female ; Follow-Up Studies ; Gastroesophageal reflux ; Humans ; Infant ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mortality ; Population ; Prevalence ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Smoking ; Studies ; United Kingdom - epidemiology</subject><ispartof>Thorax, 2018-04, Vol.73 (4), p.313-320</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</citedby><cites>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</cites><orcidid>0000-0003-0149-4869</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29074814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bloom, Chloe I</creatorcontrib><creatorcontrib>Nissen, Francis</creatorcontrib><creatorcontrib>Douglas, Ian J</creatorcontrib><creatorcontrib>Smeeth, Liam</creatorcontrib><creatorcontrib>Cullinan, Paul</creatorcontrib><creatorcontrib>Quint, Jennifer K</creatorcontrib><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><title>Thorax</title><addtitle>Thorax</addtitle><description>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Antibiotics</subject><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - drug therapy</subject><subject>Asthma - epidemiology</subject><subject>Asthma - mortality</subject><subject>Body Mass Index</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical medicine</subject><subject>Codes</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroesophageal reflux</subject><subject>Humans</subject><subject>Infant</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Population</subject><subject>Prevalence</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Smoking</subject><subject>Studies</subject><subject>United Kingdom - epidemiology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkcFO3DAURa0KVAboJxRZYsMm7bPj2OMlGgFFHakb2GLZjt1kSOLBdiS662_we3xJM8qUBStWT3r33KundxH6SuAbISX_npsQ9fNm6AoKRBSUAK_gE1oQxpdFSSU_QAsABgUvBT9CxyltAGBJiPiMjqgEwZaELdDD1bO2Lhqd2zDg2KZHrIca20ZHbbObFrMSPM6Nw_c_X_--JKxTbnqNt2E7drPuY-hxO3g95IRzwKGrsf7tTtGh111yX_bzBN1fX92tfhTrXze3q8t1YRitcuEZGOuprLn1bik9lEZazrn2kjBdOw5MW25syUnlDKucENSABVEyQqW15Qm6mHO3MTyNLmXVt8m6rtODC2NSRFaCcZCCT-j5O3QTxjhM1ykKFBgrK15NVDVTNoaUovNqG9texz-KgNoVoN4KULsC1FzA5Dvbp4-md_Wb6__HJwBmwPSbD2b-AyTklPA</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Bloom, Chloe I</creator><creator>Nissen, Francis</creator><creator>Douglas, Ian J</creator><creator>Smeeth, Liam</creator><creator>Cullinan, Paul</creator><creator>Quint, Jennifer K</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0149-4869</orcidid></search><sort><creationdate>201804</creationdate><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><author>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Antibiotics</topic><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - drug therapy</topic><topic>Asthma - epidemiology</topic><topic>Asthma - mortality</topic><topic>Body Mass Index</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical medicine</topic><topic>Codes</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroesophageal reflux</topic><topic>Humans</topic><topic>Infant</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Population</topic><topic>Prevalence</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Smoking</topic><topic>Studies</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bloom, Chloe I</creatorcontrib><creatorcontrib>Nissen, Francis</creatorcontrib><creatorcontrib>Douglas, Ian J</creatorcontrib><creatorcontrib>Smeeth, Liam</creatorcontrib><creatorcontrib>Cullinan, Paul</creatorcontrib><creatorcontrib>Quint, Jennifer K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bloom, Chloe I</au><au>Nissen, Francis</au><au>Douglas, Ian J</au><au>Smeeth, Liam</au><au>Cullinan, Paul</au><au>Quint, Jennifer K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2018-04</date><risdate>2018</risdate><volume>73</volume><issue>4</issue><spage>313</spage><epage>320</epage><pages>313-320</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29074814</pmid><doi>10.1136/thoraxjnl-2017-210650</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0149-4869</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2018-04, Vol.73 (4), p.313-320
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_miscellaneous_1957460976
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
Age
Aged
Antibiotics
Asthma
Asthma - diagnosis
Asthma - drug therapy
Asthma - epidemiology
Asthma - mortality
Body Mass Index
Child
Child, Preschool
Chronic obstructive pulmonary disease
Clinical medicine
Codes
Cohort Studies
Female
Follow-Up Studies
Gastroesophageal reflux
Humans
Infant
Kaplan-Meier Estimate
Male
Middle Aged
Mortality
Population
Prevalence
Retrospective Studies
Risk Factors
Severity of Illness Index
Smoking
Studies
United Kingdom - epidemiology
title Exacerbation risk and characterisation of the UK’s asthma population from infants to old age
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exacerbation%20risk%20and%20characterisation%20of%20the%20UK%E2%80%99s%20asthma%20population%20from%20infants%20to%20old%20age&rft.jtitle=Thorax&rft.au=Bloom,%20Chloe%20I&rft.date=2018-04&rft.volume=73&rft.issue=4&rft.spage=313&rft.epage=320&rft.pages=313-320&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thoraxjnl-2017-210650&rft_dat=%3Cproquest_cross%3E2020443565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2020443565&rft_id=info:pmid/29074814&rfr_iscdi=true